相关实验视频
Updated: Mar 10, 2026

06:02
Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model
Published on: July 26, 2011
37.5K
下调血小板内皮细胞粘附分子-1 增强学习和记忆,缓解阿尔茨海默病的标志性病理
Qiuzhi Zhou1,2,3, Fei Sun1, Yao Zhang4
1Department of Pathophysiology School of Basic Medicine Key Laboratory of Education Ministry of China/Hubei Province For Neurological Disorders, Tongji Medical College Huazhong University of Science and Technology Wuhan China.
MedComm
|March 9, 2026
概括
CD31 (血小板内皮细胞粘附分子-1) 在阿尔茨海默病 (AD) 大脑中升高. 通过向神经炎症,减少CD31改善了认知功能,并减少了AD病理.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,没有治愈方法.
- 识别新的生物标志物和治疗点对于有效的AD治疗至关重要.
研究的目的:
- 为了研究CD31 (血小板内皮细胞粘附分子-1,PECAM1) 在阿尔茨海默氏病的发病过程中的作用.
- 探索CD31作为阿尔茨海默病的潜在治疗点.
主要方法:
- 在人类AD大脑和AD转基因小鼠模型中量化CD31mRNA和蛋白质水平.
- 在5xFAD小鼠中对CD31的系统性淘汰.
- 评估认知功能,阿尔茨海默病理 (粉样β,),神经炎症和基因表达.
- 涉及基因素乳化,STAT1和IRF1.1的机制研究.
主要成果:
- 在AD大脑中,CD31水平显著升高,与AD病理相关.
- 在5xFAD小鼠中,系统性CD31敲击改善了认知功能,并减少了粉样β和病理.
- 通过降低微质激活和促炎性细胞因子表达,CD31敲击减轻了神经炎症.
- CD31 knockdown调节基因表达与AD和神经炎症相关,部分通过基因素乳化变化.
结论:
- CD31在阿尔茨海默氏症中被上调,并导致其病理和神经炎症.
- 向CD31代表了阿尔茨海默病的有希望的治疗策略.
- CD31 knockdown 影响关键的分子通路,包括基因素乳化,STAT1 和 IRF1,影响AD的进展.
相关概念视频
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Long-term Depression
3.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
3.5K
Long-term Depression
33.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.6K
Alzheimer's Disease: Treatment
1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K

